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Summary  19 
Gene expression programs determine cell fate in embryonic development and their 20 
dysregulation results in disease. Transcription factors (TFs) control gene expression by 21 
binding to enhancers, but how TFs select and activate their target enhancers is still unclear. 22 
HOX TFs share conserved homeodomains with highly similar sequence recognition 23 
properties, yet they impart the identity of different animal body parts. To understand how 24 
HOX TFs control their specific transcriptional programs in vivo, we compared HOXA2 and 25 
HOXA3 binding profiles in the mouse embryo. HOXA2 and HOXA3 directly cooperate with 26 
TALE TFs and selectively target different subsets of a broad TALE chromatin platform. 27 
Binding of HOX and tissue-specific TFs convert low affinity TALE binding into high 28 
confidence, tissue-specific binding events, which bear the mark of active enhancers. We 29 
propose that HOX paralogs, alone and in combination with tissue-specific TFs, generate 30 
tissue-specific transcriptional outputs by modulating the activity of TALE TFs at selected 31 
enhancers. 32 
 33 
Introduction  34 
Gene expression programs instruct and maintain cell fate in embryonic development and 35 
adult tissue homeostasis. Transcription factors (TFs) control gene expression by binding to 36 
enhancers (Reiter et al., 2017; Spitz and Furlong, 2012). However, we still have no clear 37 
idea of how TFs select their precise sets of target enhancers. While TFs contain DNA 38 
binding domains which recognize DNA in a sequence-specific manner, these interactions 39 
are typically insufficient to direct a TF to its functional targets.  40 
Transcriptional regulation is mediated by TFs working together, rather than in isolation. The 41 
widespread occurrence of collaborative TF binding is imposed by chromatin. A single TF 42 
cannot easily compete with nucleosomes to access DNA, but multiple TFs that recognize 43 
closely spaced binding sites can effectively displace nucleosomes and indirectly facilitate 44 
each other’s binding (Mirny, 2010; Moyle-Heyrman et al., 2011). Such indirect cooperativity 45 
can also result in TFs recognizing low affinity sites, i.e. sites that deviate from their optimal 46 
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consensus in vitro (Farley et al., 2015). Recent observations indicate that TF cooperativity 47 
does not end at binding enhancers: clusters of enhancer-bound TFs concentrate co-48 
activators and other nuclear factors via dynamic fuzzy interactions, driven by their 49 
intrinsically disordered regions (IDRs).  IDRs function in molecular recognition and mediate 50 
the interaction with a diversity of regulatory proteins (Cumberworth et al., 2013; Staby et al., 51 
2017) to promote the liquid-liquid phase transition associated with gene activation (Boija et 52 
al., 2018). Thus, the formation, on DNA segments, of regulatory complexes made of different 53 
combinations of factors, is key to activation of gene expression. These distinct combinations 54 
of TFs produce virtually inexhaustible flavours of gene expression and cell fate (Spitz and 55 
Furlong, 2012). 56 
HOX TFs provide an ideal model to explain how TFs select their target enhancers to direct 57 
specific transcriptional programs in vivo. They contain a homeodomain (HD), a highly 58 
conserved DNA binding moiety shared by hundreds of TFs (Bobola and Merabet, 2017; 59 
Burglin and Affolter, 2016). HD display highly similar sequence recognition properties and 60 
bind the same core of four-base-pair sequence TAAT (Noyes et al., 2008), yet HOX TFs 61 
function to establish the identity of entirely different body parts along the antero–posterior 62 
axis of all bilaterian animals (Krumlauf, 1994; Pearson et al., 2005). In mammals, there are 63 
39 Hox genes, classified into anterior (HOX1-2), central (HOX3–8), and posterior (HOX 9–64 
13) paralog groups (Rezsohazy et al., 2015). HOX paralogs occupy sequential positions 65 
along the chromosome, which are faithfully maintained across evolution (Duboule, 2007). 66 
This translates into precise HOX expression codes at different levels of the antero-posterior 67 
axis, conferring specific spatial and temporal coordinates to each cell.  68 
HOX association with three amino acid loop extension (TALE) HD TFs PBX, and PBX 69 
partner MEIS, is a widely accepted mechanism underlying HOX target specificity (Bobola 70 
and Merabet, 2017; Merabet and Mann, 2016; Selleri et al., 2019).  HOX-TALE cooperativity 71 
increases the affinity and sequence selectivity of HOX TFs in vitro (Merabet and Mann, 72 
2016). In vivo, HOXA2 extensively binds with TALE TFs (Amin et al., 2015) and Ubx and Hth 73 
(fly homologs to vertebrate central HOX and MEIS respectively) co-localize in active nuclear 74 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/871640doi: bioRxiv preprint first posted online Dec. 11, 2019; 
 4 
microenvironments, suggesting that their interaction may be critical to trigger phase 75 
separation (Tsai et al., 2017). Interestingly, Hox binding selectivity can be observed in the 76 
absence of TALE TFs, and is strongly associated with chromatin accessibility (Porcelli, 77 
2019).  Although the concept of HOX and TALE interaction is long established, we still 78 
understand relatively little about the extent and functional significance of HOX-TALE 79 
association in vivo, where compaction of DNA into chromatin and the distribution of 80 
sequence-specific TFs (cell-specific and tissue-specific, but also ubiquitous) can 81 
considerably affect TF binding to DNA. Also, how the association with fairly ubiquitous 82 
proteins eventually translates into HOX paralog-specific transcriptional outputs in vivo, 83 
remains unclear.  84 
To understand how HOX TFs execute their specific functions to impart different segmental 85 
identity in vivo, we compared binding of HOXA2 and HOXA3, an anterior and a central HOX 86 
proteins, in the physiological tissues where these TFs are active. Branchial arches (BA) are 87 
blocks of embryonic tissues that merge to form the face and the neck in vertebrates. The 88 
second and third branchial arch (BA2 and BA3) are the main domains of HOXA2 and 89 
HOXA3 expression respectively, and the embryonic areas most affected by inactivation of 90 
Hoxa2 and Hoxa3 in mouse (Gendron-Maguire et al., 1993; Manley and Capecchi, 1995; 91 
Rijli et al., 1993). We find that HOXA2 and HOXA3 occupy a large set of high-confidence, 92 
non-overlapping genomic regions, that are also bound by TALE TFs. We identify three main 93 
determinants of HOX paralog-selective binding, resulting in high-confidence cooperative 94 
HOX-TALE binding at different genomic locations: recognition of unique variants of the HOX-95 
PBX motif, differential affinity at shared HOX-PBX motifs and, additional contribution of 96 
tissue-specific TFs. We propose that HOX paralogs operate, alone and in concert with 97 
tissue-specific TFs, to switch on TALE function at selected enhancers. 98 
 99 
Results 100 
HOXA2 and HOXA3 control diverse processes by targeting different regions of the 101 
genome  102 
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HOX TFs direct highly specific gene expression programs in vivo, but recognize very similar 103 
DNA sequences in vitro. However, it remains to be determined if HOX specificity of action 104 
reflects specificity of binding across the genome in vivo, i.e. the binding of paralog HOX TFs 105 
to distinct target regions. To establish this, we compared HOXA2 and HOXA3 binding 106 
profiles in their physiological domains of expression in the mouse embryo. BAs display an 107 
antero-posterior gradient of HOX expression, which replicates Hox gene positions on the 108 
chromosome (Fig. 1AB): BA1 does not express any Hox gene, BA2 expresses Hox2 109 
paralogs, BA3 Hox3 paralogs, etc. We previously characterized HOXA2 binding in BA2 110 
(Amin et al., 2015); here, we profiled HOXA3 binding in BA3-4-6 (hereafter referred to as 111 
posterior branchial arches, PBA), the embryonic tissues immediately posterior to the BA2 112 
(identified by the expression of Hox paralogs 3-5, Fig. 1AB). Using a HOXA3-specific 113 
antibody (Fig. 1- Supplemental Fig. 1A), we identified 848 peaks with fold enrichment (FE) 114 
 10, which largely contained a second biological replicate (Fig. 1- Supplemental Fig. 1B). 115 
TALE TFs (PBX and MEIS) display cooperative binding with HOX and increase HOX binding 116 
specificity in vitro (Merabet and Mann, 2016). De novo motif discovery (Heinz et al., 2010) 117 
identified HOX-PBX recognition sequence as the top enriched motif in HOXA3 peaks and 118 
uncovered MEIS binding site in the top three sequence motifs (Fig. 1- Supplemental Fig. 119 
1C). HOXA3 recognition sites in PBA correspond to HOXA2 motifs in BA2; moreover, the 120 
distribution of HOX-PBX motifs is comparable across HOXA2 and HOXA3 peaks. HOX 121 
peaks without a canonical HOX-PBX consensus motif, contain potential low affinity variants 122 
of HOX-PBX sites (Fig. 1- Supplemental Fig. 1D-F). The occurrence of high affinity sites 123 
(perfect matches) positively correlates with peak FE, and is highest in top HOXA2 and 124 
HOXA3 peaks. Low affinity sites (1 mismatch) show the opposite trend and occur with higher 125 
frequency in lower confidence binding events (Fig. 1- Supplemental Fig. 1D-F).  126 
We overlapped HOXA2 binding in BA2 with HOXA3 binding in PBA. About half of HOXA3 127 
peaks are contained in the larger HOXA2 datasets (Fig. 1CD). When comparing the same 128 
number of peaks for both datasets, ranked by FE, we observed an increasing overlap at 129 
lower confidence peaks (Fig. 1E), suggesting that HOXA2 and HOXA3 select different sites 130 
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when binding with higher affinity and are more promiscuous at lower binding levels. 131 
Functional association of HOXA3-specific peaks in PBA and HOXA2-specific peaks in BA2 132 
(McLean et al., 2010)(Fig. 1FG) highlights distinct biological processes and mouse 133 
phenotypes, including abnormal middle ear, sphenoid, temporal and squamosal bone 134 
morphologies, whose morphogenesis is controlled by HOXA2 (Gendron-Maguire et al., 135 
1993; Rijli et al., 1993). In contrast HOXA3-specific binding is almost exclusively associated 136 
with heart and cardiac muscle development and cardiovascular phenotypes, consistent with 137 
the role of HOXA3 in the formation of the main arteries (Manley and Capecchi, 1995, 1997) 138 
(Fig. 1F). These observations are in line with HOX functional specificity and indicate that in 139 
their physiological domains of expression, HOXA2 and HOXA3 bind in the vicinity of, and 140 
potentially control, genes involved in very different processes. Hoxa2 expression displays a 141 
sharp anterior border between BA1 and BA2 and expands in the more posterior PBA (Fig. 142 
1A; Fig. 4A). We profiled HOXA2 binding in PBA to understand if HOX-specific binding is 143 
determined by differences in the BA2 and PBA chromatin environment. We found that 144 
HOXA2 peaks in PBA very rarely overlap with HOXA3 ‘only’ peaks in the same tissue (1% 145 
overlap), but are largely contained in the pool of HOXA2-specific binding in BA2 and 146 
‘common’ HOXA2 and HOXA3 binding events (Fig. 1H). This argues against differences in 147 
chromatin accessibility being a main determinant of HOX binding. In sum, analysis of 148 
HOXA2 and HOXA3 ChIP-seq in their respective domains of expression indicates that 149 
different HOX TFs control diverse and specific processes by targeting different regions of the 150 
genome in vivo. Tissue-specific chromatin accessibility does not appear to be a major 151 
determinant in HOX paralogs’ target site selection.  152 
HOXA2 and HOXA3 select variants of the HOX/PBX motif  153 
The observations above indicate that HOXA2 and HOXA3 select different genomic sites in 154 
vivo, while at a first glance, they recognize very similar DNA sequences. To investigate the 155 
determinants of HOX binding specificity, we focused on high confidence HOXA2 and 156 
HOXA3 peaks, which display the lowest overlap across the genome (Fig. 1E). De novo motif 157 
discovery identified enrichment of a HOX-PBX variant in HOXA3 top 250 peaks, which 158 
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contains a C in the second variable position (i.e. TGATNCAT) (Fig. 2A). We next counted 159 
the distribution of all permutations of the TGATNNAT motif in top HOXA2 and HOXA3 peaks 160 
and found the TGATTCAT variant to be highly differentially enriched in HOXA3 peaks (Fig. 161 
2B). This sequence, which is highly represented in HOXA3 top peaks (~ 20%), is almost 162 
excluded from HOXA2 peaks (Fig. 2B). Supporting functional significance, HOXA3 peaks 163 
containing TGATTCAT display increased acetylation levels (a mark of active enhancers) 164 
(Creyghton et al., 2010) in HOXA3-expressing tissues (Fig. 2C). In addition, while HOXA2 165 
peaks display a very high representation of TGATGGAT and TGATTGAT, HOXA3 high 166 
confidence binding allows higher variability (four variants are counted > 20 times in HOXA3 167 
peaks as opposed to only two variants in top HOXA2 peaks) (Fig. 2B). The highest 168 
differential enrichment of TGATNNAT variants is observed in top HOXA2 and HOXA3 peaks 169 
(Fig. 2- Supplemental Fig. 1A), which also display minimal overlap across the genome (Fig. 170 
1E); this suggests that the ability to recognize different sequences plays a role in genomic 171 
site selections. Finally, the majority of HOXA3 (158/250) and HOXA2 (160/250) top peaks 172 
contain MEIS recognition motif, at a preferential distance of less than 20 nt from the 173 
TGATNNAT motif (Fig. 2- Supplemental Fig. 1B). The Sulf2 locus exemplifies HOXA3 174 
specific binding in PBA: it contains a single TGATTCAT motif and displays high HOXA3 175 
occupancy, but no detectable HOXA2 binding (Fig. 2DE). We used electrophoretic mobility 176 
shift assay (EMSA) to establish if HOXA3 preferentially recognizes the TGATTCAT 177 
sequence in vitro. We did not observe any HOXA2 or HOXA3 binding to the Sulf2 probe 178 
(Fig. 2F). Incubation with PBX and MEIS resulted in a probe shift. Addition of HOXA3, but 179 
not HOXA2, resulted in the formation of a ternary complex, indicating that HOXA3 can bind 180 
this site in combination with PBX and MEIS, while HOXA2 cannot (Fig. 2F). In support of this 181 
conclusion, converting TGATTCAT to TGATTGAT (a single nucleotide substitution in the 182 
Sulf2 probe), enables binding of HOXA2, in addition to HOXA3 (Fig. 2G). These results 183 
indicate that HOXA3 and HOXA2 have diverse binding preferences and uncover the 184 
existence of sites that are exclusively recognized by HOXA3.  185 
HOXA2 molecular control of BA2 identity 186 
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In contrast to HOXA3, which displays unique binding preferences for TGATTCAT, we did not 187 
detect HOX-PBX variants exclusively recognized by HOXA2. To investigate the mechanisms 188 
underlying HOXA2 control of BA2 identity, we examined HOXA2 binding events (top peaks) 189 
in the vicinity of well-established HOXA2 downstream targets.  Meis2 and Zfp703 are 190 
associated with high levels of HOXA2 binding (Amin et al., 2015) (Fig. 3A and Fig. 3- 191 
Supplemental Fig. 1A) and are downregulated in Hoxa2 null BA2 (Donaldson et al., 2012). In 192 
addition, consistent with Meis2 and Zfp703 expression being HOXA2-dependent, they are 193 
expressed at higher levels in BA2 than the HOX-less BA1 and the HOXA3-positive PBA 194 
(Fig. 3B). Meis2 and Zfp703 loci exhibit high HOXA2 and HOXA3 binding in their vicinity, 195 
suggesting their associated chromatin is largely accessible in both BA2 and PBA (Fig. 3A 196 
and Fig. 3- Supplemental Fig. 1A). We focused primarily on the Meis2 enhancer, which is 197 
active in the main domains of HOXA2 expression, the hindbrain and BAs in zebrafish (Fig. 198 
3C). When tested in a luciferase assay, the Meis2 functional enhancer displays higher 199 
activity in the presence of HOXA2, in combination with MEIS and PBX, relative to HOXA3 200 
(Fig. 3D). Meis2 enhancer activity is strictly dependent on the integrity of its HOX-PBX site 201 
(Fig. 3D and Fig. 3F). Similar results were obtained with Zfp703 putative enhancer, however 202 
in this case, HOXA2 and HOXA3 alone resulted in higher activation, presumably due to the 203 
presence of additional TAAT sites around the HOX/PBX motif (Fig. 3- Supplemental Fig. 204 
1B). As for the Meis2 enhancer, disruption of the HOX/PBX site nearly abolished activation 205 
(Fig. 3- Supplemental Fig. 1B). Finally, HOXD3, another HOX paralog group 3, also 206 
displayed a lower activating capacity than HOXA2 (Fig. 3- Supplemental Fig. 1C). In sum, 207 
HOXA2 is more efficient at activating both target regions, in the presence of PBX and MEIS. 208 
To understand if this reflects HOXA2 and HOXA3 different DNA binding properties, we 209 
generated HOX chimeric proteins by swapping HOXA2 and HOXA3 DNA-binding HDs. We 210 
found that providing HOXA2 with HOXA3 HD did not substantially change the ability of 211 
HOXA2 to activate transcription from the Meis2 enhancer (Fig. 3E). Similarly, the ability of 212 
HOXA3 to transactivate the Meis2 and Zfp703 enhancers, alone or in complex with MEIS 213 
and PBX, was not improved by swapping HOXA3 HD with HOXA2 HD (Fig. 3E and Fig. 3- 214 
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Supplemental Fig. 1B). As HOX TFs cooperate with MEIS and PBX to activate target 215 
enhancers and activation relies on the presence of an intact HOX/PBX motif, HOXA2 and 216 
HOXA3 diverse activation properties may depend on their respective abilities to interact with 217 
PBX and MEIS on DNA. On their own, HOXA2 and HOXA3 weakly bind the Meis2 218 
enhancer, but interact with PBX and MEIS to form a ternary protein complex on DNA (Fig. 219 
3G-H). A larger fraction of MEIS-PBX complex is bound by HOXA2, while addition of HOXA3 220 
result in a less robust supershift (Fig. 3GH). We observed the same binding patterns using 221 
HOX chimeras: swapping HOXA3-HD with HOXA2-HD did not improve the ability of HOXA3 222 
to form a ternary complex with PBX and MEIS, and did not affect HOXA2 ability to bind DNA 223 
in complex with MEIS and PBX (Fig. 3I). Finally, altering the sequence of the HOX-PBX 224 
motif abolished formation of a HOX-MEIS-PBX complex on DNA (Fig. 3J). These results 225 
indicate that the differential ability of HOXA2 and HOXA3 to bind and activate transcription 226 
does not depend on HOX-DNA binary binding. Rather, it reflects differential abilities to form 227 
functional HOX-TALE complexes on DNA and is encoded by residues outside the HOXA2 228 
and HOXA3 HD. In summary, while HOXA2 does not exclusively access its sites (HOXA3 229 
can bind as well, Fig. 3A), HOXA2 binds more efficiently with TALE at these sites, leading to 230 
increased transcriptional activation. Consistently, shared high-confidence HOXA2 and 231 
HOXA3 binding events are largely associated with genes expressed at higher levels in the 232 
BA2 (Fig. 3K). Thus, at least in part, HOXA2 instructs the formation of a BA2 by raising the 233 
expression levels of HOX-regulated genes. Crucially, among these genes is Meis2, which 234 
encodes a critical component for BA2 identity (Amin et al., 2015).  235 
HOXA2 activity is decreased in PBA 236 
The above results show that HOXA2 functions more efficiently with TALE relative to HOXA3. 237 
Given that HOXA2 is expressed in both the BA2 and in the PBA, why does HOXA2 not 238 
instruct a BA2-specific program in the PBA as well? More posterior Hox genes are typically 239 
able to repress the expression (and suppress the function) of more anterior genes, a 240 
process termed ‘posterior prevalence’ (Duboule, 2007). Indeed, Hoxa2 highest expression is 241 
detected in the BA2, while Hoxa2 is expressed at lower levels in Hoxa3 main domain of 242 
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expression, the BA3 (Fig. 4AB and Fig. 1B). To assess how changes in HOXA2 dose affect 243 
binding genome-wide, we compared HOXA2 binding in BA2 and in PBA. While HOXA2 244 
binds similar locations in BA2 and PBA (Fig. 1H), HOXA2 binding levels are typically higher 245 
in BA2 (Fig. 4C, see also Fig. 3- Supplemental Fig. 1A). This is further confirmed by 246 
quantitative analysis of selected regions (Fig. 4D).  Relative to BA2 cells, cells in the PBA 247 
display lower levels of HOXA2 and also express HOXA3 (Fig. 1B). We investigated the 248 
effect of decreasing HOXA2 levels and increasing HOXA3 levels on HOXA2 target 249 
enhancers. We found that co-expressing HOXA2 and HOXA3 reduced activation of HOXA2 250 
target enhancers in vitro (Fig. 4E). In conclusion, a lower dose of HOXA2 decreases HOXA2 251 
binding and activating abilities. This effect, combined with the lower efficiency of HOXA3 to 252 
activate HOXA2 targets, dampens HOXA2 transcriptional program in the PBA.  253 
HOX directly cooperates with MEIS  254 
Our results indicate that HOX selectivity is displayed in concert with TALE. Generally, 255 
binding with TALE appears to be a dominant feature of HOX binding in the BAs. HOX peaks 256 
are enriched in HOX-PBX and MEIS motifs and similar to HOXA2 in BA2 (Amin et al., 2015), 257 
HOXA3 peaks overlap almost entirely with MEIS and PBX peaks in the same embryonic 258 
tissue at the same stage (Fig. 5A, Fig. 5- Supplemental Fig. 1A). We previously discovered 259 
that HOXA2 switches its transcriptional program by increasing binding of MEIS TFs to 260 
potentially lower-affinity sites across the genome (Amin et al., 2015). We investigated if 261 
HOXA3 can similarly increase MEIS binding levels. The fraction of MEIS peaks that overlaps 262 
HOXA3 binding displays higher FE in PBA, relative to the HOX-free BA1 (Fig. 5B). Hoxa2 is 263 
also expressed in PBA, where it could be entirely responsible for the observed increase in 264 
MEIS binding. Therefore, to assess HOXA3 unique contribution to MEIS binding increase, 265 
we extracted HOXA3-specific binding.  We found that MEIS peaks in PBA that overlap 266 
HOXA3 ‘exclusive’ peaks, display higher FE (relative to MEIS non-overlapping HOX), 267 
indicating that HOXA3 also increases binding of MEIS (Fig. 5C), similar to HOXA2 in BA2 268 
(Amin et al., 2015) (FigS5). Reciprocally, co-occupancy with MEIS enhances HOXA3 269 
binding (Fig. 5D).  Both HOXA2 and HOXA3 interact with MEIS1 and MEIS2 (Fig. 5E), 270 
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identifying direct cooperativity as the underlying mechanism.  Direct cooperativity with MEIS 271 
appears to be a general operational principle of HOX TFs as, similar to HOXA2 and HOXA3, 272 
MEIS co-occupancy with HOXA1 and HOXA9 is associated with the highest MEIS binding 273 
levels in mouse embryonic stem cells (De Kumar et al., 2017) and bone marrow cells 274 
(Huang et al., 2012) respectively (Fig. 5- Supplemental Fig. 1B-D). In sum, HOX directly 275 
cooperate with TALE on chromatin. As HOXA2 and HOXA3 display sequence preferences 276 
and diverse binding affinities, HOX paralogs preferentially cooperate with distinct subsets of 277 
TALE binding events. 278 
MEIS ‘ubiquitous’ binding is converted into tissue-specific enhancer activity.  279 
MEIS TFs bind broadly and to largely overlapping locations across different BAs (Fig. 6A) 280 
(Amin et al., 2015), and only a small fraction of TALE-bound regions is occupied by HOX 281 
(Fig. 5- Supplemental Fig. 1A). HOX-MEIS cooperativity predicts that the fraction of high 282 
MEIS peaks in HOX-positive areas (BA2 and PBA), should be enriched in HOX motifs. We 283 
systematically extracted differential MEIS binding across the BAs (Fig. 6- Supplemental 284 
Fig.1) and found, using convolutional neural network (CNN) models, that differential 285 
classification of MEIS binding is sufficient to uncover HOX motif features (Phuycharoen et 286 
al., 2019); specifically, the fraction of MEIS peaks higher in BA2 and in PBA (= lower BA1) is 287 
highly enriched in sequence features matching HOX-PBX motif (Fig. 6B). Interestingly, the 288 
same CNN models identify enrichment of other TF recognition motifs in differential MEIS 289 
binding (Fig. 6B). These signature motifs reflect a differential distribution of TFs across the 290 
BAs (Fig. 6C). Moreover, CNN models detect established TF interactions (Jolma et al., 291 
2015), as well as TF co-occupancy detected in vivo (Losa et al., 2017). Namely, GATA 292 
recognition motifs are enriched in higher MEIS binding in PBA, and GATA TFs are 293 
exclusively expressed in PBA (Fig. 6C), where GATA6 and MEIS bind overlapping locations. 294 
These observations suggest that other tissue-specific TFs, in addition to HOX, can affect 295 
MEIS binding to chromatin. Next, we globally quantified changes in enhancer activity across 296 
the BAs to assess the function of MEIS differential binding. Consistent with MEIS positive 297 
effects on transcription (Choe et al., 2009), regions occupied by HOXA2 in BA2, or HOXA3 298 
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in PBA, display higher enhancer activity when associated with increased MEIS binding 299 
levels in the same tissue (Fig. 6D).  More generally, higher MEIS binding levels in a tissue 300 
are highly predictive of increased enhancer activity in the same tissue (Fig. 6E), an effect 301 
only partly explained by HOX-MEIS cooperativity (Fig. 6- Supplemental Fig. 2AB). Finally, 302 
supporting the concept that MEIS ubiquitous binding (Fig. 6A) is transformed into BA-303 
specific enhancer activity, top MEIS binding is BA-specific and associated with distinct 304 
biological processes (Fig. 6FG and Fig. 6- Supplemental Fig. 2C). De novo motif discovery 305 
on HOXA3- and HOXA2-specific peaks identifies enrichment of distinctive sequence 306 
features of MEIS differential binding in PBA and BA2, NKX (HD) and FOX (Forkhead) motifs 307 
and basic helix-loop-helix (bHLH) recognition sites respectively (Fig. 6H), suggesting that 308 
HOX and tissue-specific TFs may collaborate in binding with TALE.  We focused on FOX 309 
TFs, because Fox genes are typically expressed at higher levels in PBA than BA2 (Fig. 6C). 310 
Consistent with the three factors cooperating on chromatin, HOX and FOX recognition sites 311 
co-occur in the same differential MEIS peaks (Fig. 6- Supplemental Fig. 2DE). Moreover, 312 
FOXC1 binding in the BA (Amin et al., 2015) partly overlaps with HOXA2 and HOXA3 313 
binding (Fig. 6- Supplemental Fig. 2F). FOXC1, HOX and MEIS/PBX synergize to increase 314 
transcriptional activation driven by the Sfrp2 distal region (co-occupied by HOX and FOXC1) 315 
(Fig. 6I). Interestingly, the presence of FOXC1 is sufficient to enhance MEIS/HOX 316 
transcriptional activation of Sfrp2 enhancer, suggesting that cooperation between these TFs 317 
could partly compensate for lack of PBX (Fig. 6I). While FOXC1 display similar cooperativity 318 
with TALE and HOXA2 or HOXA3 in vitro, the higher levels of FOX TFs in the PBA, relative 319 
to BA2, predict FOX TFs to have stronger effects on HOXA3 and MEIS binding in PBA; this 320 
expectation is supported by the enrichment of FOX motifs in HOXA3 and MEIS differential 321 
binding in PBA, but not HOXA2 and MEIS differential binding in BA2 (Fig. 6BH). Indeed, in 322 
silico mutagenesis predicts mutations in FOX TF recognition sites to affect binding of both 323 
HOXA3 and MEIS in PBA, but not HOXA2 and MEIS in BA2 (Fig. 6J, Fig. 6- Supplemental 324 
Fig. 2G). In contrast, mutagenesis of GATA motifs (enriched in MEIS differential peaks, but 325 
not in HOX peaks) does not appear to affect HOX-MEIS binding (Fig. 6J). These results 326 
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identify (direct or indirect) cooperativity with tissue-specific TFs as an additional mechanism 327 
for HOX selectivity. We propose that HOX and tissue-specific TFs (alone and in 328 
combination) increase TALE TF binding affinity and residence time at selected locations, 329 
identified using their sequence recognition motifs.  Increasing MEIS residence time on 330 
chromatin has a positive effect on enhancer activity and results in BA-specific transcriptional 331 
outputs. Thus, TALE TFs function as a hub which integrates different signals instructing BA 332 
morphogenesis.   333 
 334 
Discussion 335 
HOX TFs contain a HD, which display highly similar sequence recognition properties and is 336 
shared by hundreds of TFs, yet they instruct diverse, segment-specific transcriptional 337 
programs along the antero-posterior axis of all bilaterian animals. By profiling HOXA2 and 338 
HOXA3 binding in their physiological domains, we identify three main determinants of HOX-339 
selective binding across the genome: 1) recognition of unique variants of the HOX-PBX 340 
motif; 2) differential affinity at ‘shared’ HOX-PBX motifs and; 3) presence of additional tissue-341 
specific, non-TALE, TFs. These mechanisms (with the possible exception of the first) are 342 
expected to generate quantitative (rather than qualitative, i.e. binding/no binding) differences 343 
in the relative levels of HOX/TALE occupancy on commonly bound regions. Such 344 
quantitative changes are a feature of continuous networks (Biggin, 2011), in which TFs bind 345 
a  continuum of functional and non-functional  sites and regulatory specificities derive from 346 
quantitative differences in DNA occupancy patterns.  347 
HOX paralog-selective binding occurs in cooperation with TALE. The high degree of 348 
HOX and TALE interaction flexibility, mediated by paralog-specific protein signatures, has 349 
been proposed to generate paralog-specific functions of HOX TFs (Dard et al., 2018). Here, 350 
by defining the in vivo repertoire of HOX occupied sites, we identify DNA sequence as an 351 
additional determinant of HOX-TALE functional specificity in vivo.  This finding is consistent 352 
with the mechanism of latent specificity described for Drosophila Hox/Exd (PBX) interaction 353 
(Slattery et al., 2011) and in vitro observations that HOX TFs bind longer, more specific 354 
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sequence motifs in the presence of TALE. However, the effects of TALE on HOX binding in 355 
vivo go beyond the refinement of HOX binding sites as, at least in the BA context, binding 356 
with TALE appears to be a requirement for loading HOX on chromatin. Our observations 357 
indicate that HOXA2-A3 overwhelmingly recognize genomic sites that are enriched in HOX-358 
PBX motifs and are also occupied by TALE TFs in vivo. Therefore, TALE provides a platform 359 
for HOX to bind; selectivity enables HOX paralogs to preferentially bind different subsets of 360 
this common platform. In agreement with our finding that BA-specific chromatin states do not 361 
seem to play a role in HOX target site selection, TALE platform is largely similar across BA1-362 
2-PBA. 363 
What is the functional significance of HOX-TALE interaction on chromatin and how 364 
does it contribute to paralog-specific transcriptional programs? Many examples from animal 365 
development indicate that transcriptional regulation is mediated by distinct combinations of 366 
TFs. TALE TFs operate as a hub, which assists combinatorial assembly of TF complexes. 367 
TALE platform expands HOX functional interface and enables HOX to function in concert 368 
with other TFs, bypassing the need of direct protein-protein interaction. In doing so, it 369 
integrates positional signals (encoded by HOX) and local inputs (provided by cell type-370 
/tissue-specific TFs) into defined transcriptional outputs. While it is possible that MEIS and 371 
PBX facilitate access of diverse TFs to relatively inaccessible chromatin, MEIS TFs differ 372 
from conventional pioneer TFs, which function to open chromatin regions but are not directly 373 
involved in enhancer activation (Cirillo et al., 1998; Jacobs et al., 2018). Remarkably, 374 
independently of the type of TF involved (HOX or other tissue-specific TFs), positive 375 
changes in MEIS binding result in a functional effect, i.e. increased enhancer activity. High 376 
instances of MEIS binding are typically tissue-specific and highly correlated with enhancer 377 
activity. In fact, differential MEIS binding in a specific BAs is generally a very good predictor 378 
for matching changes in enhancer activity in the same tissue. Based on our observations 379 
and the well-established role of MEIS in transcriptional activation (Choe et al., 2009; Hau et 380 
al., 2017; Hyman-Walsh et al., 2010), we propose a model of transcriptional activation, 381 
where TALE (MEIS) TFs function as a broad or general activators and HOX paralog 382 
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selectivity is mainly directed at harnessing TALE functional activity at selected locations. 383 
Using their recognition motifs, HOX and/or tissue-specific TFs select specific MEIS binding 384 
locations, where they stabilize MEIS binding to generate precise functional outputs, or 385 
patterns of enhancer activation (Fig. 7). Interestingly, MEIS2 interacts with PARP1 (Hau et 386 
al., 2017), a large enzyme capable of triggering phase condensation (Altmeyer et al., 2015). 387 
Increasing MEIS residence time (as a result of the cooperation with HOX and other TFs) 388 
may favour PARP1 recruitment at selected loci and, in turn, generate the liquid-liquid phase 389 
transitions observed to promote gene activation (Boija et al., 2018; Hnisz et al., 2017).  390 
Because high instances of MEIS binding are typically associated with combinatorial TF 391 
binding, a precise identification of the critical steps for enhancer activation, and their 392 
sequential order, remains problematic. For similar reasons, MEIS and PBX shared genomic 393 
occupancy complicates dissecting their respective contributions to enhancer binding and 394 
activation. In addition to TALE, numerous other TFs are broadly, if not ubiquitously 395 
expressed during development, yet their inactivation results in tissue-specific phenotypes. It 396 
is tempting to speculate that similar principles of TF functional connectivity could explain 397 
other transcriptional networks, i.e. that cell type- tissue-specific regulators harness the 398 
activation abilities of broadly expressed TFs to generate cell type -specific gene expression 399 
programs. 400 
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 412 
Material and methods 413 
Animal experiments 414 
CD1 mice were time-mated to obtain BA2 or PBA from E115 embryos. Mouse experiments 415 
were carried out under ASPA 1986. Wild type zebrafish were raised in the University of 416 
Massachusetts Medical Center Zebrafish Facility. Embryos and adult zebrafish were 417 
maintained under standard laboratory conditions. Enhancers were amplified from mouse 418 
genomic DNA using the primers (listed in S), cloned into pCR8/GW/TOPO vector (Life 419 
Technologies) and recombined using the Gateway system (Life Technologies) to an 420 
enhancer test vector that includes a strong midbrain enhancer (Minitol2-GwB-zgata2-GFP-421 
48, a kind gift from JL Skarmeta) as an internal control. Fertilized zebrafish embryos were 422 
collected from natural spawnings. Plasmid DNA was injected into the cytoplasm of one-cell 423 
stage embryos. Injected embryos were visualized intermittently by fluorescence microscopy 424 
up to 48 hr post fertilization to identify transgenic carriers. These were raised to adulthood, 425 
outcrossed to wildtype fish and the resulting F1 embryos were scored for GFP expression in 426 
order to generate stable transgenic lines. 427 
Next-generation sequencing data and downstream analyses 428 
ChIP-seq was performed as described (Losa et al., 2017) using rabbit polyclonal antibodies 429 
targeting HOXA3 (non-conserved N-terminal amino acids 24 to 180), HOXA2 (Kutejova et 430 
al., 2008), PBX1-2-3-4 (sc-25411X, Santa Cruz) and rabbit IgG (Millipore). DNA was 431 
recovered from two independent ChIP-seq experiments and purified using DiaPure columns 432 
(Diagenode). Enrichment was validated by SYBR green quantitative PCR (qPCR) using 433 
primers listed in Table S1. DNA libraries were constructed using the MicroPlex Library 434 
Preparation Kit v2 (Diagenode) and sequenced with the Illumina next generation sequencing 435 
platform. ChIP-seq experiments were analysed using Trimmomatic for trimming (Bolger et 436 
al., 2014), Bowtie2 for aligning to the mouse genome (mm9) (Langmead and Salzberg, 437 
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2012), samtools  (Li et al., 2009) to remove the aligned reads with a mapping quality Q30 438 
and MACS2 for peak calling (Zhang et al., 2008) with default narrow peak calling setting for 439 
TFs and broad peak calling setting for histone modification marks. ‘findMotifGenome’ 440 
module of the HOMER package was used to detect de novo motif in 200nt summit regions 441 
(Heinz et al., 2010). Venn diagrams were generated using 200nt peak summits with an 442 
overlap of at least 1nt. GREAT standard association rule settings (McLean et al., 2010) was 443 
used to associate ChIP-seq peaks with genes and uncover events controlled by TF binding. 444 
DiffBind (Ross-Innes et al., 2012) was used to re-center MEIS and H3K27ac peaks across 445 
BA1, BA2 and PBA (Figure 6_supplemental Fig. 1) and calculate RPKM values and raw 446 
counts in the re-centered regions. edgeR generalized linear model (GLM) method with TMM 447 
normalization (Robinson et al., 2010) was used to select differential peaks and calculate fold 448 
change in MEIS binding and H3K27ac across BAs used to generate boxplots and 449 
scatterplots. The best H3K27Ac replicate [highest FRiPs (fraction of reads in peaks)] RPKM 450 
values was used to produce boxplots. Gene expression CPM values and differential gene 451 
expression at E10.5 and E11.5 were derived from (Amin et al., 2015; Losa et al., 2017). 452 
ggplot2 package (Wickham, 2016) was used to generate CPM values heatmap. GALAXY 453 
(Geocks et al 2010), Bioconductor GenomicRanges package (Lawrence et al., 2013), and 454 
Bioconductor ChIPpeakAnno package 455 
(https://www.bioconductor.org/packages//2.10/bioc/html/ChIPpeakAnno.html) were used to 456 
intersect, modify and visualize genomic coordinates. Bioconductor Biostring (Pagès H, 2019) 457 
was used to locate fixed motif sequences in the binding regions. Distance between HOX and 458 
MEIS binding regions was calculated using GenomicRanges package and plotted with 459 
ggplot2. The Kernel density distribution of MEIS fold enrichment in HOX binding regions vs 460 
non-HOX binding regions were calculated by R kernel density distribution estimation (R core 461 
team 2013) and plotted with ggplot2. 462 
All RNA-seq and ChIP-seq datasets are available on the ArrayExpress with accession 463 
numbers: E-MTAB-7963, E-MTAB-7966, E-MTAB-7766, E-MTAB-7767, E-MTAB-5394, E-464 
MTAB-5407, E-MTAB-5536, E-MTAB-2696. 465 
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Convolutional neural network models and in silico mutagenesis 466 
MEIS differential sequence features are detected by recently published differential 467 
convolutional neural network (CNN) structure (Phuycharoen et al., 2019). For in silico 468 
binding site knockout we trained a convolutional neural network (CNN) model for multitask 469 
regression of MEIS and HOX RPKM binding level. The CNN was trained by transfer 470 
learning, using convolution parameters from a previously published 1-convolutional layer 471 
MEIS RPKM model (Phuycharoen et al., 2019). Convolutional filters were transferred to a 472 
new model, which was then trained on a subset of MEIS regions also bound by HOX, to 473 
simultaneously predict log2RPKM values in 2 replicates of Hoxa2 in BA2, 2 from Hoxa3 in 474 
PBA, and one replicate of MEIS in BA1, BA2 and PBA. The training data consisted of 6795 475 
regions of 600nt with HOX binding predicted by MACS2 in any tissue. The regression model 476 
was subsequently used to predict the change in RPKM values after binding site erasure. For 477 
simulated genomic knockout, a 25nt site containing each feature was replaced by random 478 
di-nucleotides from the remaining part of the region and RPKM levels were predicted. 479 
Random replacement was repeated 100 times for each feature, averaging the predicted 480 
RPKM change. To select candidate features for erasure, MEIS PBA up-binding features 481 
were first obtained from the previously published 3-task parallel model and subsequently 482 
filtered. Sites of HOXA3 and GATA were required to contain consensus motif “TGATNNAT” 483 
and “WGATAA” respectively, with no mismatch allowed. Forkhead sites were selected 484 
based on long distinct k-mers, derived from KSM motif representation method (Guo et al., 485 
2018), namely exact matches to any of the following sequences: “AAAATAAACA", 486 
"AAAAATAAAC", "AATAAATCAA", "ATNAATCAACA", "AAATAAACAC", 487 
"ATAAATCAAC","GAAAATAAAC", "CAAAATAAAC", "AAAATAAACT",  "AAATAAACAA".  488 
These candidate sites were identified within a +/- 250nt window centred on HOXA3 and 489 
GATA6 ChIP-seq peak summits, FE of replicates was combined with edgeR (Robinson et al. 490 
2010) and a Poisson test was performed as in MACS2 using false discovery rate (FDR) 491 
cutoff = 0.05. Only Forkhead and GATA motifs that did not contain internal matches to HOX-492 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/871640doi: bioRxiv preprint first posted online Dec. 11, 2019; 
 19
PBX motif were selected. Subsets of GATA and Forkhead sites located within +/- 100nt from 493 
a HOX-PBX sites were selected for mutagenesis.  494 
Elecrophoretic mobility shift assays  495 
Probes were made from primers with 5’ ATO700, and purified with QIAGEN PCR purification 496 
kit (Qiagen). Proteins were generated using TnT® Quick Coupled Transcription/Translation 497 
System (Promega) and the following plasmids: pcDNA3-Hoxa2, pcDNA3-Hoxa3, pcDNA3-498 
Meis2, containing mouse coding sequences for Hoxa2, Hoxa3 and Meis2 (isoform 1), cloned 499 
into pcDNA3 (Invitrogen); pcDNA3-PBX1a is a gift from Francesco Blasi. Reactions (4% 500 
Ficoll, 20mM HEPES, 37.5mM KCl, 1mM DTT, 0.1mM EDTA, 2ug Poly dI.dC, 16ng probe, 501 
and 2ul of TNT extracts in total volume of 10ul) were mixed by gentle flicking, and incubated 502 
at room temperature for 12 minutes before being run on 3% / 4% acrylamide gel at 70V in 503 
0.5X TBE.  504 
Luciferase assay 505 
Meis2 and Zfp703 enhancers were amplified from mouse genomic DNA using primers listed 506 
in Table S1 cloned into pCR8/GW/TOPO vector (Life Technologies) and recombined using 507 
the Gateway system (Life Technologies) into pGL4.23-GW (a gift from Jorge Ferrer; 508 
Addgene plasmid # 60323; http://n2t.net/addgene:60323 ; RRID:Addgene_60323).  509 
Enhancers were co-transfected with pcDNA3, pcDNA3-Hoxa2, pcDNA3-Hoxa3, pcDNA3-510 
Meis2, pcDNA3-PBX1a (described above) and pcDNA3-Hoxd3 generated by GenScript. 511 
NIH3T3 cells were grown in DMEM (D6429) supplemented with 10% FBS and 5% 512 
penicillin/streptomycin, and seeded in 24-well plates at 100,000 cells/ml. Cells were 513 
transfected with GeneJuice Transfection Reagent (Novagen), using 250ng luciferase 514 
plasmid and 300ng pcDNA3 plasmids per well. Cells were harvested 24 hours after 515 
transfection and luciferase measured using Luciferase Assay System and the GloMax Multi-516 
Detection System (Promega).  517 
Antibody validation  518 
Gateway® entry vectors for mouse Hoxb1 and Hoxb2 (Bridoux & al. 2015 PubMed PMID: 519 
26303204), human HOXA3 and HOXC4 (http://horfdb.dfci.harvard.edu/hv7/) were used to 520 
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generate mammalian expression vectors for FLAG-HOX (v1899 destination vector) using the 521 
gateway technology (Barrios-Rodiles et al., 2005). Gateway® expression vectors for 522 
pExpFLAG-Hoxa1 and pExpFLAG-Hoxa2 are described in (Bergiers et al., 2013; Lambert et 523 
al., 2012). HEK293 cells were grown at 37°C, in a humidified atmosphere with 5% CO2 in 524 
DMEM (D6429) supplemented with 10% FBS, 5% penicillin/streptomycin, and 5% L-525 
glutamine. Cells were seeded in 6-well plates at 400,000 cells/well and transfected 24 hours 526 
after plating using 1µg of HOX plasmid constructs and Fugene6 (Promega) according to the 527 
manufacturer's instructions. Proteins were collected 48 hours after transfection, boiled in 528 
Laemmli buffer, run on SDS-page and visualized using anti-FLAG (M2) (#F1804, Sigma), 529 
HRP-conjugated anti-β-ACTIN (#A3854, Sigma) and anti-Hoxa3 antibody (1:2000) and 530 
HRP- HRP-conjugated secondary antibodies. 531 
Co-immunoprecipitation experiments  532 
Coding sequences for MEIS1b and MEIS2.1 were cloned in pEnt plasmids, confirmed by 533 
DNA sequencing and used to generate pExp mammalian expression vectors for GST-534 
tagged proteins with the pDest-GST N-terminal destination vector using the gateway 535 
technology (Rual et al., 2005). HEK293 cells were transfected as above, using 500ng each 536 
of FLAG/GST constructs per well. Proteins were collected 48 hours after transfection and 537 
co-precipitation performed as described in (Bridoux et al., 2015). 538 
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Figure legends 698 
Figure 1. HOXA2 and HOXA3 control diverse processes by targeting different regions 699 
of the genome in vivo. A. BA organization in mammals. BA3-6 are collectively indicated as 700 
PBA. The same colour code (BA2 red, PBA green) is used throughout the manuscript. B. 701 
Heatmap of Hox expression in E10.5 mouse BA1, BA2 and PBA, based on the normalized 702 
expression values count per million (CPM)(Losa et al., 2017). C. Overlap of HOXA3 binding 703 
in PBA and HOXA2 binding in BA2 (200 nt summits, overlap at least 1 nt). Only peaks with 704 
FE 10 are considered. D. UCSC tracks (mm9) of HOXA3 (green) and HOXA2 (red) specific 705 
and shared peaks. E. Overlap (%) of increasing numbers of top HOXA2 and HOXA3 peaks 706 
(ranked by FE). High-confidence peaks show the smallest overlap. FG. GREAT analysis of 707 
HOXA3- (F) and HOXA2- (G) specific peaks (non-overlapping, green and red bars 708 
respectively) shows association with genes involved in different biological processes and 709 
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whose mutations generate different phenotypes in mouse. The length of the bars 710 
corresponds to the binomial raw (uncorrected) P-values (x-axis values). H. HOXA2 binding 711 
in PBA. Overlap of HOXA2 summit regions in PBA (FE  10, green) with HOXA2 summit 712 
regions in the BA2 (red) and HOXA3 summit regions in the PBA (green); same rule as in C. 713 
HOXA2 binding locations are similar in BA2 and PBA. 714 
Figure 2. HOXA2 and HOXA3 select variants of the HOX/PBX motif. A. Homer detects 715 
different variants of the HOX-PBX motif in top 250 HOXA2 and HOXA3 peaks, with a G/C 716 
(HOXA3) or mainly a G (HOXA2) in the second variable position. B. Occurrence of HOX-717 
PBX motif variants (all permutations of the variable nucleotides in TGATNNAT) in top 250 718 
HOXA2 and HOXA3 peaks (ordered into 50 region bins). The TGATTCAT motif (red arrows) 719 
is among the most enriched variants in HOXA3 peaks but does not virtually occur in HOXA2 720 
peaks. C. Box plot of global H3K27 acetylation levels (PBA/BA2 ratio) at HOXA3 peaks 721 
containing different TGATNNAT variants. HOXA3 peaks containing the TGATTCAT variant 722 
are associated with increased enhancer activity in PBA (red line). D. UCSC tracks with 723 
HOXA3, HOXA2, PBX and MEIS binding profiles in BA2 (red) and PBA (green) at the Sulf2 724 
locus, containing TGATTCAT. No HOXA2 binding is detected in BA2 or PBA. E. Sequence 725 
of HOXA3 peak summit in D, corresponding to the probe used in F. The TGATTCAT motif 726 
(underlined) is flanked by two MEIS motifs (also underlined); the C G substitution tested in 727 
G is indicated in red. F. HOXA3 can selectively bind the Sulf2 probe in complex with 728 
PBX/MEIS. Incubation of the Sulf2 probe with TNT reticulocyte expressing HOXA2, HOXA3, 729 
MEIS/PBX, HOXA2/MEIS/PBX or HOXA3/MEIS/PBX. MEIS/PBX bind the Sulf2 probe in 730 
combination (arrow). Addition of HOXA3 to the probe results in the formation of a complex 731 
only in the presence of PBX/MEIS (arrow). No complex is formed when PBX/MEIS are co-732 
translated with HOXA2. G. Same experiment as in F, using a mutant Sulf2 probe (the 733 
nucleotide substitution is shown in E). HOXA2 can bind the mutant probe in combination 734 
with MEIS/PBX (asterisk), similar to HOXA3 (arrow). 735 
Figure 3. HOXA2 control of target enhancers. A. UCSC tracks of HOXA2, HOXA3, PBX, 736 
MEIS binding and H3K27 acetylation profiles in BA2 (red) and PBA (green) at the Meis2 737 
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locus. Strong HOX and TALE binding is observed in both tissues, with higher acetylation 738 
levels in BA2. B. Heatmap shows Meis2 and Zfp703 expression in E11.5 mouse BA1, BA2 739 
and PBA, based on the normalized expression values CPM (Losa et al., 2017). C. Meis2 740 
enhancer is active in the hindbrain (h) and the BAs (ba, arrow) of developing zebrafish, 741 
which correspond to Meis2 expression domains in mouse (Amin et al., 2015). The enhancer 742 
sequence spans the 200nt summit of HOXA2 peak in A. D. Luciferase activity driven by 743 
Meis2 enhancer co-transfected with Hoxa2 (red bar) or Hoxa3 (green bar) in combination 744 
with Meis2 and Pbx1a expression vectors in NIH3T3 cells. The combination of Hoxa2 with 745 
Meis2 and Pbx1a results in the highest activation. Changing the HOX-PBX site (empty bars, 746 
mutant sequence in F) reduces HOX-TALE activation. E. Luciferase activity driven by Meis2 747 
enhancer co-transfected with Hoxa2-a3HD (red empty bar) or Hoxa3-a2HD (green empty 748 
bar) and Meis2 and Pbx1a. Values shown in DE represent fold activation over basal 749 
enhancer activity and are presented as the average of at least two independent 750 
experiments, each performed in triplicate. Error bars represent the standard error of the 751 
mean (SEM). F. Sequence of Meis2 wild-type and mutant probe. HOX-PBX (reverse) and 752 
MEIS motifs are underlined. Nucleotide substitution in the HOX-PBX site are shown in red. 753 
G-J. Incubation of the Meis2 probe with TNT reticulocyte expressing HOXA2, HOXA3, 754 
MEIS/PBX, HOXA2/MEIS/PBX or HOXA3/MEIS/PBX as indicated. G-H. HOXA2 (G, red 755 
arrow) and HOXA3 (H, green arrow) weakly bind the Meis2 probe. MEIS and PBX bind DNA 756 
together (black arrow). Addition of HOXA2 results in a trimeric protein complex (arrowhead); 757 
the intensity of the MEIS/PBX complex is reduced (black arrow). Addition of HOXA3 results 758 
in a higher complex (arrowhead), but without affecting the intensity of the MEIS/PBX dimeric 759 
complex (black arrow). I. Swapping HOXA3-HD with HOXA2-HD does not improve the ability 760 
of HOXA3 to form a ternary complex with PBX and MEIS, and does not decrease HOXA2 761 
binding with MEIS and PBX (arrowheads). Adding HOXA2 (or HOXA2-A3HD) results in 762 
higher intensity of the trimeric complex and lower intensity of TALE dimeric complex relative 763 
to HOXA3 (or HOXA3-A2HD), as observed in G-H. J. Meis2 mutant probe (sequence in F) 764 
does not interact with HOX and/or TALE. K. Top HOXA2 and HOXA3 overlapping peaks 765 
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(total of 60 intersecting top 250 HOXA2 and HOXA3 peaks) are more frequently associated 766 
with genes with higher expression in BA2 (red) relative to PBA (green). The white portion of 767 
the pie chart refers to genes that are not differentially expressed (no DE). Gene association 768 
is based on GREAT standard association rules; expression levels are extracted from E11.5 769 
RNA-seq (Losa et al., 2017).  770 
Figure 4. AB. In situ hybridization on E9.5 embryos, using Hoxa2 (A) and Hoxa3 (B) probes. 771 
A. Hoxa2 is highly expressed in the neural crest migrating from rhombomere 4 (asterisk) to 772 
the BA2 (arrow). The portion of neural crest migrating just below the otic vesicle (OV) into 773 
the BA3 (arrowhead) is also Hoxa2-positive. B. Hoxa3 is expressed in the BA3 (arrowhead). 774 
C. Boxplots of FE of HOXA2 peaks in BA2 and PBA. D. Comparison of HOXA2 binding in 775 
BA2 (red bars) and PBA (green bars) by ChIP-qPCR. Enrichment of each region following 776 
immunoprecipitation with HOXA2 and IgG negative control antibody (Neg Ab) is calculated 777 
as percentage input; numbers indicate the corresponding FE values in HOXA2 ChIP-seq 778 
(BA2 and PBA). Peaks are labelled by their closest genes. Itih4 is a negative control 779 
(unbound region). Values represent the average of duplicate samples, and error bars 780 
indicate the SEM. D. Luciferase activity driven by Meis2 and Zfp703 enhancers co-781 
transfected with expression vector for Hoxa2 or Hoxa3, alone, or at diverse ratio of Hoxa2 to 782 
Hoxa3 (3:1; 2:2; 1:3) as indicated. All samples, except the negative control, contain Hox in in 783 
combination with Meis2 and Pbx1a expression vectors. For both enhancers, luciferase 784 
activity decreases as Hoxa2 is progressively replaced by Hoxa3. Values represent fold 785 
activation over basal enhancer activity and are presented as the average of at least two 786 
independent experiments, each performed in triplicate. Error bars represent the SEM. 787 
Figure 5. HOX directly cooperate with MEIS. A. Overlap of HOXA3 with MEIS and PBX 788 
peaks in the same tissue (PBA) and at the same embryonic stage (E11.5) (200nt summit 789 
regions, overlap at least 1nt). The proportional Venn diagram is cropped to focus on HOXA3 790 
peaks. B. Barplots of fold change in MEIS binding levels in PBA versus BA1. Regions co-791 
occupied by MEIS with HOXA3 in PBA generally display higher MEIS binding levels in PBA 792 
(HOX-positive) relative to the HOX-negative BA1. In contrast, MEIS binding not overlapping 793 
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HOXA3 can be higher in BA1 or in PBA. Fold changes were calculated using EdgeR (see 794 
also Figure 6- figure Supplement 1). C. Kernel density plots of MEIS peaks relative to FE 795 
(PBA). MEIS binding is sorted into peaks not overlapping HOX (light green), MEIS peaks 796 
overlapping HOXA3 only (‘exclusive’ peaks, i.e. not overlapping HOXA2 in PBA, darker 797 
green) and MEIS peaks overlapping HOXA2 and HOXA3 (darkest green). D. Distance of 798 
HOXA3 peaks relative to MEIS peaks (PBA). HOXA3 peaks are binned according to their 799 
log10 distance to the nearest MEIS peak and labelled according to FE (high FE, dark red 800 
bars; low FE, dark blue bars). E. Co-immunoprecipitation assays. HEK293T cells were co-801 
transfected with expression vectors for FLAG-tagged HOXA2 or HOXA3 and GST-tagged 802 
MEIS1, GST-tagged MEIS2 or GST alone. Protein interactions were assayed by co-803 
immunoprecipitation on glutathione beads directed toward the GST tag and eluted proteins 804 
analysed by western blotting to detect the presence of HOXA2-FLAG or HOXA3-FLAG (red 805 
box, Co-IP). Cell lysates were analysed by western blotting prior to co-immuno precipitation 806 
to detect protein expression (input).  807 
Figure 6. A. Proportional Venn diagram shows highly overlapping binding of MEIS in BA1, 808 
BA2 and PBA. Out of 215830 MEIS peaks, 101055 are in common between the three 809 
tissues; MEIS peaks were combined and re-centered using DiffBind. B. CNN models of 810 
MEIS differential peaks uncover enrichment of tissue-specific sequence motifs as described 811 
in (Phuycharoen et al., 2019). MEIS binding was classified in six categories (i.e. peaks with 812 
higher/lower binding in BA1, BA2, PBA). CNN analysis identifies tissue-specific sequence 813 
features in each class of MEIS peaks. Predicted GATA binding in a MEIS PBA up-binding 814 
region is visualised as in the example (a feature matching GATA TF recognition motif on 815 
chr5:104257972-104258015 is shown) and annotated using HOMER. The GATA6 ChIP-seq 816 
verifies this prediction. HOMER was used to cluster and annotate tissue-specific sequence 817 
features; differentially enriched features are matched to TF families with known tissue-818 
specificity (see also Fig. 6C). C. Heatmap of the expression of selected TF families, 819 
corresponding to cognate recognition motifs identified in MEIS PBA-up, in E11.5 mouse BA2 820 
and PBA. Members of the GATA and TBX families, and the majority of expressed Forkhead 821 
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TFs are enriched in PBA relative to BA2. Only TFs with expression values > 10 cpm in at 822 
least one tissue are shown. D. Boxplots of the ratio of H3K27ac (log2RPKM) in BA2 and PBA 823 
for all HOX peaks and for HOX peaks overlapping MEIS differential binding higher in BA2 824 
(HOXA2 peaks) and higher in PBA (HOXA3 peaks). HOX binding generally increases 825 
H3K27Ac; peaks associated with increased MEIS binding display a higher increment of 826 
H3K27Ac in the same tissue. E. Correlation plot of differential MEIS binding and differential 827 
acetylation (enhancer activity) at intergenic regions (PBA versus BA2). Each point 828 
corresponds to a region with MEIS log2 fold change >1 (FC>2); the corresponding H3K27ac 829 
value is plotted. Changes in MEIS binding levels are positively correlated with increased 830 
enhancer activity in the same tissue (correlation = 0.73). F. Different top MEIS peaks are 831 
observed in different BAs. The ratio of MEIS peaks, which are common to BA2 and PBA, 832 
increases as FE decreases. G. UCSC tracks illustrates MEIS increased binding at the 833 
Zfp496 and Zfpm1 loci. Instances of common MEIS peaks higher in one tissue (PBA) are 834 
shaded. H. HOMER de novo motif discovery in HOXA3-specific and HOXA2-specific peaks. 835 
HOXA3-specific are HOXA3 peaks excluding peaks overlapping with HOXA2 BA2; similarly, 836 
HOXA2-specific are HOXA2 peaks excluding peaks overlapping with HOXA3 PBA. HOMER 837 
identifies enrichment of the same motifs enriched in BA-specific MEIS differential binding, 838 
Forkhead motif in HOXA3-specific (shaded in green) and BHLH motif in HOXA2-specific 839 
subsets (shaded in red).  Variations of HD recognition motifs potentially recognized by HOX 840 
and attributed by HOMER to PBA-specific TFs NKX and ISL1 in PBA and LHX/DLX in BA2 841 
are also enriched. I. Luciferase activity driven by Sfrp2 enhancer co-transfected with Meis, 842 
and Meis and Pbx with and without Hoxa2 (red empty bars), Hoxa3 (green empty bars) and 843 
Foxc1 (grey) in 3T3 cells. Adding Foxc1 to Hoxa2 or Hoxa3 with Meis2 and Pbx1a results in 844 
the highest activation. J. In silico knockout of Forkhead and GATA motifs is used to predict 845 
the effects on HOX and MEIS binding.  CNN MEIS PBA ‘up-binding’ features (Fig. 6B) were 846 
annotated as HOX, GATA, and Forkhead (see methods). Co-occurring HOX- Forkhead 847 
motifs (distance between 1 nt to 100 nt) were selected for in silico mutagenesis. Forkhead 848 
mutagenesis results in a significant drop in HOXA3 binding in PBA, but shows no average 849 
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significant effect on HOXA2 in BA2. Similarly, Forkhead mutagenesis significantly decreases 850 
Meis PBA binding across most tested sites. In comparison, much weaker effects are 851 
predicted on BA1 and BA2 MEIS differential binding. As a negative control, the same 852 
procedure was applied to co-occurring HOX-GATA motifs. GATA motif mutagenesis does 853 
not show significant average effects on HOX, or MEIS in HOX-bound regions.  854 
Figure 7. Model. Low affinity, widespread binding of MEIS (blue square) defines a large 855 
subset of accessible chromatin (grey line) for activation (PBX is not shown as PBX and 856 
MEIS binding almost entirely overlaps). Direct cooperativity with HOX (A2 and A3, red and 857 
green circles respectively) and/or indirect cooperativity with tissue-specific TFs (triangle) 858 
increase MEIS binding affinity and residence time; prolonged residence time of MEIS at 859 
enhancers promotes recruitment of general co-activators (yellow) and activation of 860 
transcription. HOX paralogs preferentially bind different subsets of MEIS occupied regions, 861 
resulting in differential transcription. Three examples of BA-specific transcription are shown. 862 
In a, the red site is bound with higher affinity by HOXA2 than HOXA3, resulting in the 863 
formation of a more stable HOX-TALE complex on DNA and a (higher) transcriptional output 864 
in BA2. Conversely, in c, the green site is only recognized by HOXA3, leading to high affinity 865 
MEIS binding only in PBA, and to PBA-specific transcription. In b, the effect of HOXA3 is 866 
potentiated by a PBA-specific TF binding in the vicinity. Co-binding with tissue-specific TFs 867 
may positively contribute to HOX-MEIS cooperativity by competing with nucleosome for DNA 868 
binding, especially at HOX and/or MEIS low affinity sites. These mechanisms result in BA-869 
specific transcription.  870 
 871 
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Figure 2.A, Schematic representation of BAs in a mouse/human embryo (BA1, blue; BA2, red; posterior BAs=PBA,
green). BAs appear in the developing vertebrate head as a transient series of similar segments, which take on individual
identities. BAs are colonised by neural crest cells, an attractive example of progenitor cells with multiple cell fate choices.
B, MEIS differential binding in in BA2 and PBA. While most TFs bind relatively few sites (e.g. <104) and in a tissue-
restricted manner, MEIS TFs bind very extensively (>105 sites) and largely to the same locations across the BAs.
Quantitative analysis of MEIS binding shows ‘shared’ MEIS peaks with log fold change (FC) < 3 signal (n= 6875; only
peaks with fold enrichment >10 are shown) and with higher signal (logFC ≥ 3) in BA2 (red) and in PBA (green). (C) MEIS
differential binding is highly correlated with tissue-specific enhancer activities. Correlation plot of differential MEIS binding
and differential acetylation (enhancer activity) at intergenic regions (PBA versus BA2). D, 100% (10/10) of the regions
displaying highly increased MEIS peaks in only a single tissue, function as tissue-specific enhancers when injected in
zebrafish. Example shows restricted GFP expression in the BAs and hindbrain (H). E, Convolutional neural network
models on MEIS peaks with higher signal in PBA identifies enrichment of the recognition sequence for GATA and HAND
TFs, together with motifs recognized by MEIS and MEIS partners HOX/PBX. Gata4 and Gata6, and Hand1 and Hand2
transcripts are expressed at higher levels in PBA compared to BA215 (F) UCSC browser tracks illustrate overlapping
binding of MEIS and GATA6 in PBA, with increased MEIS binding signal (grey regions) in PBA relative to BA1 and BA2.
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Meis2 wt:   GGGTATCATCAATCACAGACCACTGTGACATATGC
Meis2 mut: GGGTATCCGCACGCACAGACCACTGTGACATATGC
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